BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802
162 results:

  • 1. Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.
    Shim SH; Lee JY; Lee YY; Park JY; Lee YJ; Kim SI; Han GH; Yang EJ; Noh JJ; Yim GW; Son JH; Kim NK; Kim TH; Kong TW; Choi YJ; Cho A; Lim H; Jang EB; Cho HW; Suh DH
    J Gynecol Oncol; 2024 Mar; 35(2):e66. PubMed ID: 38330382
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The promise of combining cdk4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma.
    Ray-Coquard I; Monk BJ; Lorusso D; Mahdi H; Upadhyay V; Graul R; Husain A; Mirza MR; Slomovitz B
    Int J Gynecol Cancer; 2023 Dec; 33(12):1943-1949. PubMed ID: 37907262
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The SGK3-Catalase antioxidant signaling axis drives cervical cancer growth and therapy resistance.
    Wang M; Liu J; Liao X; Yi Y; Xue Y; Yang L; Cheng H; Liu P
    Redox Biol; 2023 Nov; 67():102931. PubMed ID: 37866161
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix.
    Kommoss FK; Lee CH; Tessier-Cloutier B; Gilks CB; Stewart CJ; von Deimling A; Köbel M
    J Pathol; 2024 Jan; 262(1):4-9. PubMed ID: 37850576
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ANXA3, associated with YAP1 regulation, participates in the proliferation and chemoresistance of cervical cancer cells.
    Huang J; Wei W; Kang F; Tan S; Li Y; Lu X; Wang N
    Genes Genomics; 2023 Dec; 45(12):1575-1586. PubMed ID: 37843781
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. uterine MEIS1::NCOA2 Fusion Sarcoma With Lung Metastasis: A Case Report and Review of the Literature.
    Xing D; Meyer CF; Gross JM; Argani P; Hung CF; Wu TC; Vang R; Armstrong DK; Gaillard SL
    Int J Gynecol Pathol; 2024 Jan; 43(1):47-55. PubMed ID: 37043646
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Aggressive High-grade uterine Sarcoma Harboring MEIS1-NCOA2 Fusion and Amplification of Multiple 12q13-15 Genes: A Case Report With Morphologic, Immunohistochemical, and Molecular Analysis.
    Niu S; Rivera-Colon G; Lucas E
    Int J Gynecol Pathol; 2023 Sep; 42(5):460-465. PubMed ID: 36811835
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive immunohistochemical analysis based on the origin of leiomyosarcoma.
    Bayçelebi D; Kefeli M; Yıldız L; Karagöz F
    Pol J Pathol; 2022; 73(3):233-243. PubMed ID: 36734438
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial cancer.
    Konstantinopoulos PA; Lee EK; Xiong N; Krasner C; Campos S; Kolin DL; Liu JF; Horowitz N; Wright AA; Bouberhan S; Penson RT; Yeku O; Bowes B; Needham H; Hayes M; Sawyer H; Polak M; Shea M; Cheng SC; Castro C; Matulonis UA
    J Clin Oncol; 2023 Jan; 41(3):599-608. PubMed ID: 36174113
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The HPV16E7 Affibody as a Novel Potential Therapeutic Agent for Treating Cervical cancer Is Likely Internalized through Dynamin and Caveolin-1 Dependent Endocytosis.
    Zhang Q; Zhu H; Cui Z; Li Y; Zhuo J; Ye J; Zhang Z; Lian Z; Du Q; Zhao KN; Zhang L; Jiang P
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009008
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Adlay Seed (
    Chiang YF; Chung CP; Lin JH; Chiang W; Chen HY; Ali M; Shih YH; Wang KL; Huang TC; Chang HY; Lin LC; Shieh TM; Hsia SM
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807238
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Novel Therapeutics in the Treatment of uterine Sarcoma.
    Bose S; Schwartz GK; Ingham M
    Am Soc Clin Oncol Educ Book; 2022 Apr; 42():900-909. PubMed ID: 35714303
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Exosomal MiR-423-3p inhibits macrophage M2 polarization to suppress the malignant progression of cervical cancer.
    Yan X; Zhang S; Jia J; Yang J; Song Y; Duan H
    Pathol Res Pract; 2022 Jul; 235():153882. PubMed ID: 35609397
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent cdk4 Pathway Alterations and MDM2 Amplifications.
    Kommoss FKF; Chiang S; Köbel M; Koelsche C; Chang KT; Irving JA; Dickson B; Thiryayi S; Rouzbahman M; Rasty G; von Deimling A; Lee CH; Turashvili G
    Am J Surg Pathol; 2022 Aug; 46(8):1142-1152. PubMed ID: 35499168
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Feasibility of the "Cuff-Sleeve" Suture Method for Functional Neocervix Reconstruction in Laparoscopic Radical Trachelectomy: A Retrospective Analysis.
    Xu M; Huo C; Huang C; Wu B; Liu Y; Li J; Ling X; Xu G; Lin Z; Lu H
    J Minim Invasive Gynecol; 2022 May; 29(5):673-682. PubMed ID: 35051658
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [A Case Report of uterine Metastasis Four Years after Breast Surgery for Breast cancer].
    Tojo K; Abe S; Tachibana K; Hoshi N; Murakami Y; Noda M; Ishigami H; Soeda S; Watanabe N; Kiko Y; Hashimoto Y; Otake T
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1885-1888. PubMed ID: 35045436
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. GLI1-altered mesenchymal tumor: a clinicopathological and molecular analysis of ten additional cases of an emerging entity.
    Liu J; Mao R; Lao IW; Yu L; Bai Q; Zhou X; Wang J
    Virchows Arch; 2022 May; 480(5):1087-1099. PubMed ID: 34779913
    [TBL] [Abstract] [Full Text] [Related]  

  • 18.
    Mardinian K; Adashek JJ; Botta GP; Kato S; Kurzrock R
    Mol Cancer Ther; 2021 Dec; 20(12):2341-2351. PubMed ID: 34642211
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial cancer Cell Lines (Ishikawa, HEC-1A, KLE).
    Chen HY; Cheng WP; Chiang YF; Hong YH; Ali M; Huang TC; Wang KL; Shieh TM; Chang HY; Hsia SM
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361036
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas.
    Lin DI; Huang RSP; Mata DA; Decker B; Danziger N; Lechpammer M; Hiemenz M; Ramkissoon SH; Ross JS; Elvin JA
    Mod Pathol; 2021 Dec; 34(12):2200-2210. PubMed ID: 34302054
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.